Anti-EGFR Immunoliposomes in Solid Tumors
NCT01702129
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
anti-EGFR immunoliposomes loaded with doxorubicin
Sponsor
University Hospital, Basel, Switzerland